| CEO: | Andrew James Webb |
| Chief Scientific Officer: | Christopher McConville |
| Independent Non-Executive Director: | Gerald Beaney |
| Non-Executive Chairman: | Nermeen Yunus Varawalla |
| Non-Executive Dir: |
| Address: | Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands, USA, |
| Phone: | +1 (925) 408 4621 |
| Website: | http://www.crismtherapeutics.com/ |
| Sector: | Investment Firms(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | VGG042401262 |
| Currency | UK Pounds |
| Share Price | 12.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 12.80 |
| 52 Week Low | 11.00 |
| Volume | 0 |
| Shares Issued | 39.96m |
| Market Cap | £4.80m |
| Value |
|
|---|
| Value |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Latest | Previous | |
|---|---|---|
| Special | Interim | |
| Ex-Div | 01-Jun-23 | n/a |
| Paid | 14-Jun-23 | n/a |
| Amount | 1.80p | 0.000¢ |
| Time | Volume / Share Price |
| 0 @ 0.000p |
| CEO | Andrew James Webb |
You are here: research